Cluster of Excellence –
University of Freiburg

Prof. Wilfried Weber

Prof. Wilfried Weber

BIOSS and Institute of Biology II (Biochemistry), University Freiburg

+49 761 203 97654

10 selected publications:

  • Control of gene expression using a red- and far-red light-responsive bi-stable toggle switch.
    Müller K, Zurbriggen MD, Weber W (2014).
    Nat Protoc. 9(3):622-32.
  • Remote-controlled hydrogel depots for time-scheduled vaccination.
    Gübeli RJ, Hövermann D, Seitz H, Rebmann B, Schoenmakers RG, Ehrbar M, El Hamri GC, El Baba MD, Werner M, Müller M, Weber W (2013).
    Adv Funct Mat. 23,5355-5362.
    Front Cover Image of Issue 23 (43).
  • Multi-chromatic control of mammalian gene expression and signaling.
    Müller K, Engesser R, Schulz S, Steinberg T, Tomakidi P, Weber CC, Ulm R, Timmer J, Zurbriggen MD, Weber W (2013).
    Nucleic Acids Res. 41(12):e124.
  • A red/far-red light-responsive bi-stable toggle switch to control gene expression in mammalian cells.
    Müller K, Engesser R, Metzger S, Schulz S, Kämpf MM, Busacker M, Steinberg T, Tomakidi P, Ehrbar M, Nagy F, Timmer J, Zubriggen MD, Weber W (2013).
    Nucleic Acids Res. 41(7):e77.
  • Synthetic mammalian gene networks as a blueprint for the design of interactive biohybrid materials.
    Jakobus K, Wend S, Weber W (2012).
    Chem Soc Rev. 41(3):1000-18.
  • Emerging biomedical applications of synthetic biology.
    Weber W, Fussenegger M (2011).
    Nat Rev Genet. 13(1):21-35.
  • Conditional DNA-protein interactions confer stimulus-sensing properties to biohybrid materials.
    Christen E, Karlsson M, Kämpf MM, Schoenmakers R, Gübeli RJ, Wischhusen HM, Friedrich C, Fussenegger M, Weber W (2011).
    Adv Func Materials 21, 2861–2867
  • A gene therapy technology-based biomaterial for the trigger-inducible release of biopharmaceuticals in mice.
    Kämpf MM, Christen EH, Ehrbar M, Daoud-El Baba M, Charpin-El Hamri G, Fussenegger M, Weber W (2010).
    Adv Func Materials 20, 2534-2538.
  • Drug-sensing hydrogels for the inducible release of biopharmaceuticals.
    Ehrbar M, Schoenmakers S, Christen E, Fussenegger M, Weber W (2008). 
    Nature Materials 7, 800-804.
  • A synthetic mammalian gene circuit reveals anti-tuberculosis compounds.
    Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sande P, Fussenegger M (2008).
    Proceedings of the National Academy of Sciences USA 105, 9994-9998.